Atlas Trials

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

Clinical trial NCT00017927 · COMPLETED

Trial details

NCT number
NCT00017927
Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
McCune Albright SyndromePolyostotic Fibrous Dysplasia
Start date
2001-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.